Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models

A Molecular Subtype–Specific Stochastic Simulation Model of US Breast Cancer Incidence, Survival, and Mortality Trends from 1975 to 2010

(2018) Diego F. Munoz et al.   MEDICAL DECISION MAKING

Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment

(2018) Diego F. Munoz et al.   MEDICAL DECISION MAKING

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

(2018) Jeanne S. Mandelblatt et al.   MEDICAL DECISION MAKING

The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update

(2018) Oguzhan Alagoz et al.   MEDICAL DECISION MAKING

Structure, Function, and Applications of the Georgetown–Einstein (GE) Breast Cancer Simulation Model

(2018) Clyde B. Schechter et al.   MEDICAL DECISION MAKING

Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches

(2018) Nicolien T. van Ravesteyn et al.   MEDICAL DECISION MAKING

Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology

(2018) Jeroen J. van den Broek et al.   MEDICAL DECISION MAKING

Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia

(2018) Jeroen J. van den Broek et al.   MEDICAL DECISION MAKING

Whose Preferences Matter? A Patient-Centered Approach for Eliciting Treatment Goals

(2017) Nananda F. Col et al.   MEDICAL DECISION MAKING

A Bayesian Simulation Model for Breast Cancer Screening, Incidence, Treatment, and Mortality

(2017) Xuelin Huang et al.   MEDICAL DECISION MAKING

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

(2016) Jeanne S. Mandelblatt et al.   ANNALS OF INTERNAL MEDICINE

Transition From Film to Digital Mammography

(2015) Nicolien T. van Ravesteyn et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts

(2015) Brian L. Sprague et al.   ANNALS OF INTERNAL MEDICINE

Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands

(2015) Valérie D.V. Sankatsing et al.   INTERNATIONAL JOURNAL OF CANCER

Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis

(2015) N. T. van Ravesteyn et al.   JNCI-Journal of the National Cancer Institute

Benefits and Harms of Mammography Screening After Age 74 Years: Model Estimates of Overdiagnosis

(2015) N. T. van Ravesteyn et al.   JNCI-Journal of the National Cancer Institute

Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits

(2014) Iris Lansdorp-Vogelaar et al.   ANNALS OF INTERNAL MEDICINE

Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography

(2014) Natasha K. Stout et al.   JNCI-Journal of the National Cancer Institute

Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

(2013) Jeanne S. Mandelblatt   ANNALS OF INTERNAL MEDICINE

Comparative Effectiveness Research: A Report From the Institute of Medicine

(2013) Harold C. Sox   ANNALS OF INTERNAL MEDICINE

Which strategies reduce breast cancer mortality most?

(2013) Jeanne Mandelblatt et al.   CANCER

The benefits and harms of breast cancer screening: an independent review

(2012)   LANCET

Model Transparency and Validation

(2012) David M. Eddy et al.   MEDICAL DECISION MAKING

Quality of Life and Guidelines for PSA Screening

(2012) Harold C. Sox   NEW ENGLAND JOURNAL OF MEDICINE